Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
March 2002
Features
Drug Shortages (4-Part Series)
Part 2: Surviving Drug Shortages Perspectives from the Hospital Pharmacy
One hospital shows how they anticipate and cope with drug shortages.
Noreen H. Chan-Tompkins, PharmD, Roxane Curinga, and Toni Fera, Pharm D
Meeting Highlights
41st Interscience Conference on Antimicrobial Agents and Chemotherapy
Lawrence M. Prescott, PhD
Book Review
“Evidence-Based Herbal Medicine”
A new book gives health care providers evidence-based information on herbal medicine.
Peter Chodoff, MD, MPH
An Economic Analysis of Alternative Step-Up Therapies in Asthma Patients Receiving Inhaled Corticosteriods
This study analyzed health care claims data to compare the costs of different asthma drug therapies.
Daniel A. Ollendorf, MPH, Alyssa S. Pozniak, BA, Brian W. Bowers, PharmD, and Gerry Oster, PhD
Continuing Education Credit
Pathogenesis and Therapy Management of Steroid-Resistant Asthma
This article discusses the possible causes of steroid-resistant asthma and treatment for patients who have it.
Stephen B. Moody, MSPharm
Guest Commentary
“ Food for Thought” Meals at Medical Meetings: Mixed Messages
Do doctors know what’s good for them when they eat at medical conferences?
John La Puma, MD, FACP
Departments
Editorial
FARS and FFIRS
Editor-in-Chief David B. Nash describes how, “FARS and FFIRS” programs can help fight medication errors.
David B. Nash, MD, MBA
Prescription Washington
Co-packaging Compliance Conundrum
Stephen Barlas
Drug News
New Drugs/Drug News
The latest information about approvals, indication changes, industry updates, and news from the FDA.
Medication Errors
Fentanyl Transdermal System: Unsafe in Inexperienced Hands
Matthew Grissinger, RPh, discusses the
possible dangers resulting from careless
use of fentanyl patches.
Matthew Grissinger, RPh
Drug Forecast
Galantamine: A New Acetylcholinesterase Inhibitor for the Treatment of Alzheimer’s Disease
A new Alzheimer’s drug that is highly selective for acetylcholinesterase.
Martin S. Maltz, RPh, MS and Harold L. Kirschenbaum, MS, PharmD
